Generalized pustular psoriasis's potential for complications
Generalised Pustular Psoriasis - Overview
GPP is an uncommon, severe, and possibly life-threatening variant of psoriasis with extensive sterile pustules, systemic inflammation, and recurring flares. It affects 1–7 per million persons worldwide, mostly women and middle-aged adults. GPP (von Zumbusch psoriasis) is a variant of pustular psoriasis that causes vast areas of skin to erupt with sterile pustules, fever, malaise, and systemic symptoms. Japan and Korea have higher prevalence estimates. It can happen at any age but is most frequent between 40 and 60. Women are slightly more affected.
Symptoms
- Skin: Erythema with sterile pustules.
- Systemic: fever, chills, tiredness, a rapid pulse, nausea, muscle weakness, and joint pain.
- Sepsis, cardiovascular failure, renal failure, and respiratory failure can result from severe flares, making GPP a medical emergency.
What distinguishes pustular psoriasis from psoriasis?
Types of GPP
- Acute GPP von Zumbusch: Sudden, painful pustules accompanying fever and sickness.
- Life-threatening Annular GPP.
- Children often have ring-shaped lesions that spread slowly.
- Permanent/Recurrent GPP Long-lasting pustules with systemic inflammation Variable severity
Key Risks and Considerations
- Emergency: Untreated GPP flares can kill. Urgent medical attention is needed.
- Risk of misdiagnosis: Drug-induced pustulosis (AGEP) and Sneddon-Wilkinson disease can mimic GPP, requiring biopsy.
- Pustular psoriasis during pregnancy can harm the mother and fetus.
Generalized pustular psoriasis causes.
Causes
Mutations in the IL36RN gene cause excessive inflammation, sometimes connected to CARD14 variations
Common GPP Triggers
1. Medications
- Most common trigger: systemic corticosteroid withdrawal.
- Onset-linked drugs:
- Chloroquine, hydroxychloroquine
- Lithium
- Amoxicillin, ceftriaxone, oxacillin
- Antifungals (terbinafine)
- Codeine painkillers
- Paradoxically, psoriasis medications (TNF-α and IL-17 inhibitors) can cause GPP flares.
2. Infections
- Streptococcal throat infections.
- SARS-CoV-2, cytomegalovirus, Epstein-Barr virus, varicella zoster.
- In predisposed people, these illnesses can cause acute flares.
3. Environmental and Physiological Factors
- Impetigo herpetiformis occurs in the third trimester of pregnancy.
- Changes in hormones can cause flares.
- Sunlight and low calcium levels are potential triggers.
- Stress and smoking might worsen symptoms.
4. Genetics
- DITRA syndrome: IL-36 receptor antagonist deficiency causes uncontrolled inflammation.
- CARD14 and AP1S3 mutations are related to GPP in some cases.
- Genetic forms often appear in childhood.
Key Risks
- Triggers can induce severe flares that require hospitalization.
- GPP is often misdiagnosed as drug-induced pustulosis (AGEP) and other pustular dermatoses.
- Long-term management requires identifying and avoiding triggers.
How serious is pustular psoriasis?
- In contrast to plaque psoriasis, pustular psoriasis can cause fever, chills, malaise, and organ stress.
- Severe flares can cause sepsis, cardiovascular failure, liver dysfunction, kidney damage, or multiorgan failure.
- During flares, 50% of GPP patients are hospitalized, often in the ICU.
- Mortality rates range from 2-7% globally, with higher rates in Asia (e.g., Malaysia ~6.9%, Korea ~6.1%).
Key Risks
- Sudden corticosteroid withdrawal, infections, pregnancy, and some drugs can cause serious flares.
- Disease severity is linked to IL36RN, CARD14, AP1S3, and MPO gene mutations.
- Obesity, diabetes, hypertension, and metabolic syndrome worsen outcomes.
Spectrum of severity
- Localized pustular psoriasis (PPP, ACH) affects palms, soles, or fingertips. Chronic, painful, but not fatal.
- Generalized pustular psoriasis involves widespread pustules and systemic disease. High-risk for death
GPP Treatment Methods
The video is about the GPP relief guide.
1. Manage emergencies
- Serious flares with fever, dehydration, or systemic sickness require hospitalization.
- Supportive care: IV fluids, electrolytes, infection monitoring, pain treatment.
- Biologics like infliximab and spesolimab decrease inflammation fast.
2. Biotherapies
- Spevigo (Spesolimab):
- FDA-approved GPP in the USA, EU, Japan, and China.
- Targets the IL-36 receptor, which drives GPP inflammation.
- IV infusion clears pustules in days.
- Other off-label biologics:
- The TNF-α inhibitor Infliximab is utilised for acute flares and has a quick onset.
- Secukinumab and ixekizumab (IL-17 inhibitors) may be effective but not widely authorised for GPP.
- Adalimumab and etanercept (TNF-α inhibitors) are utilised in Japan/Taiwan based on minor research.
3. Non-Biologic Systemic Therapies
- Retinoids (acitretin): A long-standing vitamin A-derived alternative.
- A potent immunosuppressant, cyclosporine.
- In chronic management, methotrexate slows immunological overactivity.
- Apremilast (PDE4 inhibitor): Used in multi-comorbid patients.
4. Topical/Phototherapy (Supportive)
- Phototherapy, corticosteroid creams, and synthetic vitamin D may improve localized pustular psoriasis (palms/soles), but not GPP.
Risks and Factors
- Steroid withdrawal might cause serious flares—avoid systemic corticosteroids.
- Topical corticosteroids or phototherapy are safer than retinoids during pregnancy.
- Infection risk: Immunosuppressants and biologics must be monitored.
Organs Associated with Generalised Pustular Psoriasis.
1. Primary Organ: Skin
- Due to rapid skin cell turnover, psoriasis causes red, scaly plaques.
- Chronic inflammation in the largest organ, the skin, has systemic repercussions.
2. Heart, Vessels
- Patients with psoriasis have greater cardiovascular risk.
- Chronic inflammation raises heart attack, stroke, hypertension, and atherosclerosis risks.
- Psoriasis patients have a 2–3 times higher risk of myocardial infarction than the general population.
3. Liver
- NAFLD is linked to psoriasis.
- Methotrexate and other systemic drugs might strain the liver and require monitoring.
4. Kidneys
- Chronic systemic inflammation can damage the kidneys.
- Some psoriasis therapies, such as cyclosporine, may impact renal health.
5. Lungs
- Psoriasis patients have more asthma, COPD, and pulmonary hypertension.
- Smoking and pollution damage psoriasis and lung health.
6. Nerves and brain
- Due to persistent inflammation and psychosocial stress, psoriasis may cause depression, anxiety, and dementia.
- Psoriasis flares are often caused by stress.
7. Arthritis joints
- Up to 30% of psoriasis patients acquire PsA.
- Joint discomfort and swelling can lead to severe disability if neglected.
8. Bones
- Systemic inflammation and vitamin D deficiency increase osteoporosis and fracture risk.
- Important Considerations
- Avoid systemic corticosteroids: Withdrawal causes serious flares.
- Phototherapy or biologics are safer than retinoids during pregnancy.
- Comorbidities: Diabetes, liver/kidney disease, and cardiovascular disease affect medicine choice.
Conclusion
GPP requires rapid treatment, often hospitalisation, unlike plaque psoriasis.
The approval of spesolimab (IL-36R antagonist) has revolutionized treatment, providing immediate relief and better outcomes. Traditional systemic medications like acitretin, cyclosporine, and methotrexate remain crucial.
GPP is a systemic inflammatory illness with substantial mortality and morbidity. Reducing risks and improving quality of life requires early diagnosis, trigger avoidance, and current biologic therapy.






